Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook
More News

Advanced Photonix to Merge with Jenner Biotherapies

Facebook Twitter LinkedIn Email Comments
CAMARILLO, Calif., Sept. 28 -- Advanced Photonix Inc. said that it had completed its negotiations with Jenner Biotherapies Inc. and entered into a letter of intent in which Jenner would merge with a newly formed subsidiary of API.

The terms of the transaction call for the stockholders of Jenner to receive 28,586,457 shares of API's common stock, plus (or minus) an additional number of shares of common stock. This is to be determined by dividing the amount by which Jenner's current assets exceed (or are less than) its total liabilities at the effective time of the merger, by the average closing price of the common stock over the 10 business days preceding the effective time of the merger (but in no event more than $1.50 or less than $.50 a share).


Photonics.com
Sep 2001
News & Features

Comments
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2019 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, info@photonics.com

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.